Skip to main content
Article
Evaluating immune checkpoint inhibition in solid tumor patients with homologous recombination repair deficiency.
Journal of Clinical Oncology (2018)
  • Fernando Manuel Vargas Madueno, Baptist Hospital of Miami
  • Wenrui Duan, Florida International University
  • Zuanel Diaz, Miami Cancer Institute, Miami, FL;
  • John Paul Diaz, Miami Cancer Institute, Miami, FL;
  • Federico Albrecht, Miami Cancer Institute, Miami, FL;
  • Siddharta Venkatappa, Miami Cancer Institute, Miami, FL;
  • Eric Douglas Schroeder, Miami Cancer Institute, Miami, FL;
  • Santiago Aparo, Montefiore Medical Center
  • Vanessa Yanek, Miami Cancer Institute, Miami, FL;
  • Gail Walker, Miami Cancer Institute, Miami, FL, US;
  • Miguel Villalona, Miami Cancer Institute, Miami, FL;
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.tps3108
Citation Information
Fernando Manuel Vargas Madueno, Wenrui Duan, Zuanel Diaz, John Paul Diaz, et al.. "Evaluating immune checkpoint inhibition in solid tumor patients with homologous recombination repair deficiency." Journal of Clinical Oncology Vol. 36 (2018)
Available at: http://works.bepress.com/santiago-aparo/38/